Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemia

Autor: Luo, Meng-Xiao 1, 2, Tan, Tania 1, 2, Trussart, Marie 1, 2, Poch, Annika 2, 3, Nguyen, Thi Minh Hanh 2, 3, Speed, Terence P. 1, 2, Hicks, Damien G. 4, Bandala-Sanchez, Esther 1, 2, Peng, Hongke 1, 2, Chappaz, Stéphane 5, Slade, Charlotte 1, 2, Utzschneider, Daniel T. 2, 3, Koldej, Rachel M. 2, 6, Ritchie, David 2, 6, 7, Strasser, Andreas 1, 2, Thijssen, Rachel 1, 2, Ritchie, Matthew E. 1, 2, Tam, Constantine S. 5, 8, Lindeman, Geoffrey J. 1, 2, 9, Huang, David C. S. 1, 2, Lew, Thomas E. 1, 2, 7, 9, Anderson, Mary Ann 1, 2, 7, 9, Roberts, Andrew W. 1, 2, 7, 9, Teh, Charis E. 1, 2, ∗, Gray, Daniel H. D. 1, 2, ∗∗
Zdroj: In Blood 26 December 2024 144(26):2748-2761
Databáze: ScienceDirect